Decrease of Cellular Communication Network Factor 1 (CCN1) Attenuates PTZ-Kindled Epilepsy in Mice

Yiwei Liao1,2, Sha Huang2,3,4, Yuhu Zhang5

  • 1Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, 410008, China.

PubMed

Insights

Communication network factor 1 (CCN1) is elevated in epilepsy and contributes to seizure pathogenesis. Reducing CCN1 protects the brain by decreasing neuronal apoptosis and oxidative stress, offering potential therapeutic targets for epilepsy.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pathology

Background:

  • Epileptogenesis involves complex molecular mechanisms.
  • Communication network factor 1 (CCN1) role in epilepsy is not fully understood.
  • Identifying novel therapeutic targets for epilepsy is crucial.

Purpose of the Study:

  • To elucidate the molecular mechanism of CCN1 in pentylenetetrazol (PTZ)-induced epileptogenesis.
  • To deepen the understanding of epilepsy seizure pathogenesis.
  • To identify potential drug targets for clinical prevention and treatment of epilepsy.

Main Methods:

  • Analysis of differentially expressed genes (DEGs) from microarray datasets (GSE47516, GSE88992) using GEO2R.
  • Pathway enrichment and protein-protein interaction (PPI) network analysis via Metascape.
  • qRT-PCR and immunohistochemistry (IHC) on human epilepsy and control brain tissues.
  • Establishment and verification of a PTZ-induced epilepsy mouse model.
  • Hematoxylin and eosin (HE) staining for neuronal morphology.
  • qRT-PCR for apoptosis-related genes (Bax, Caspase-3, Bcl2).
  • TUNEL staining for neuronal apoptosis.
  • Biochemical assays for myocardial enzymes, GSH, MDA, and ROS.

Main Results:

  • CCN1 expression was significantly increased in epilepsy brain tissues.
  • Decreasing CCN1 prolonged seizure incubation and reduced seizure duration in a PTZ-induced epilepsy model.
  • CCN1 silencing reduced neuronal damage and apoptosis, decreasing pro-apoptotic proteins (Bax, Caspase-3) and increasing anti-apoptotic protein (Bcl2).
  • Reduced CCN1 levels decreased myocardial injury markers (CK, CK-MB), myocardial hemorrhage, and alleviated oxidative stress in hippocampal and myocardial tissues.
  • CCN1 reduction protected brain tissue by attenuating oxidative stress and inhibiting neuronal apoptosis, likely via the Nrf2/HO-1 pathway.

Conclusions:

  • CCN1 is upregulated in epilepsy and plays a critical role in PTZ-induced epileptogenesis.
  • Downregulation of CCN1 demonstrates neuroprotective effects by inhibiting apoptosis and oxidative stress.
  • CCN1 represents a promising therapeutic target for epilepsy treatment.